US 12390453
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
granted A61KA61K31/44A61K45/06
Quick answer
US patent 12390453 (Method for reducing side effects from administration of phosphodiesterase-4 inhibitors) held by ARCUTIS BIOTHERAPEUTICS, INC. expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCUTIS BIOTHERAPEUTICS, INC.
- Grant date
- Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/44, A61K45/06, A61K47/10, A61K47/24